"Mendelian randomisation and experimental medicine approaches to interleukin-6 as a drug target in pulmonary arterial hypertension." Mark Toshner, Colin Church, Lars Harbaum, et al . Eur Respir J 2022; 59: 2002463
The European respiratory journal, 2022-07, Vol.60 (1), p.2052463 [Peer Reviewed Journal]ISSN: 0903-1936 ;EISSN: 1399-3003 ;DOI: 10.1183/13993003.52463-2020 ;PMID: 35798371
Full text available